Roohollah Mirzaee Khalilabadi

Dr. Roohollah Mirzaee Khalilabadi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
NGNarges Ghasemimehr
Narges Ghasemimehr
AFAlireza Farsinejad
Alireza Farsinejad
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
ZYZinat Yazdani
Zinat Yazdani
AFAhmad Fatemi
Ahmad Fatemi

25 July 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MLMahla Lashkari
Mahla Lashkari
AFAhmad Fatemi
Ahmad Fatemi
HVHajar Mardani Valandani
Hajar Mardani Valandani
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
One of the heterogeneous hematologic malignancies of the lymphocyte precursors is ALL. ALL has two incidence peaks that were determined in 2–5 years children and 60 years old adults. Cardiotoxicity of chemotherapeutic drugs is one of important side effects which may occur during or after chemotherapy period. The aim of this study was to evaluate the effect of ZME, Dox, and combinations on Nalm-6 cells. In this vein, the cell viability was assessed by Trypan blue and MTT assay. Evaluation of apoptosis was also analyzed by Annexin-V/PI staining. Moreover, the expression of Bax, Bcl-2, Bcl-xl, hTERT, c-Myc, P53, and P21 genes was detected by Real-Time PCR. Molecular docking as an in-silico method was performed for Bcl-2 and Bcl-xl proteins as well. Our achievements indicated that ZME had dose-dependent effect on Nalm-6 cells and ZME synergistically potentiated Dox effect. The expression of Bax, P53 and P21 genes increased although the expression of Bcl-2 genes decreased when cells treated with ZME/ Dox combination. Molecular docking showed the interactions of carvacrol and thymol in the active cavities of BCL2 and BCL-xl. Regarding to present study, ZME could be utilized as a combinatorial and potential drug for leukemic patients, which is under the treatment by Dox due to reducing the chemotherapy drug doses.


22 January 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MKMaryam Katoueezadeh
Maryam Katoueezadeh
PMParisa Maleki
Parisa Maleki
STSeyedeh Atekeh Torabizadeh
Seyedeh Atekeh Torabizadeh
AFAlireza Farsinejad
Alireza Farsinejad
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
AFAhmad Fatemi
Ahmad Fatemi

1 September 2020 in Gene Reports
Verified
Journal Article
Closed access
HAHussein Anani
Hussein Anani
IBIman Baluchi
Iman Baluchi
AFAlireza Farsinejad
Alireza Farsinejad
AFAhmad Fatemi
Ahmad Fatemi
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi

1 August 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MPMaryam Samareh Salavati Pour
Maryam Samareh Salavati Pour
FKFatemeh Hoseinpour Kasgari
Fatemeh Hoseinpour Kasgari
AFAlireza Farsinejad
Alireza Farsinejad
AFAhmad Fatemi
Ahmad Fatemi
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
Background: Due to their self-renewal and differentiation ability, the mesenchymal stem cells (MSCs) have been studied extensively. However, the MSCs lifespan is restricted; they undergo several divisions in vitro that cause several alternations in cellular features and relatively lessens their application. Thus, this study was aimed to assess the effect of platelet-derived microparticles (PMPs), a valuable source of proteins, microRNAs (miRNAs), and growth factors, on the expression of hTERT, c-MYC, p16, p53, and p21 as the most important aging and cell longevity genes alongside with population doubling time (PDT) of PMP-treated cells in comparison to a control group. Methods: Umbilical cord MSCs (UC-MSCs) were used in this study, whereby they reached a confluency of 30%. MSCs were treated by PMPs (50 µg/mL), and then, PDT was determined for both groups. Quantitative expression of hTERT, c-MYC, p16, p53, and p21 was examined through quantitative real-time PCR at various intervals (i.e. after five and thirty days as well as freezing-thawing process). Results: Our results demonstrated that the treated group had a shorter PDT in comparison to the control group (P<0.050). The real-Time PCR data also indicated that PMPs were able to remarkably up-regulate hTERT and c-MYC genes expression while down-regulating the expression of p16, p21, and p53 genes (P<0.050), especially following five days of treatment. Conclusion: According to these data, it appears that PMPs are a safe and effective candidate for prolonging the lifespan of UC-MSCs; however, further investigations are needed to corroborate this finding.